MHRA Signals Major Update in Rare Disease Treatments
The MHRA in the UK is planning major reforms to accelerate the development, testing, and approval of rare disease therapies, aiming to overcome current barriers and make treatments more accessible, supported by a new framework and collaborative efforts to position the UK as a global leader in rare disease innovation.